SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " turn " 13,205 found 🔀 AI-powered Shuffle
Miles Bridges trade grades: Suns burn another potential rebuild year, Hornets add to draft pick pile
The asset-rich Charlotte front office got a home run return with the 2033 first-round pick
Former local star B.J. Daniels advocates for mental health awareness
Former Lincoln and NFL standout B.J. Daniels turns personal struggles into a message of hope for athletes everywhere.
Inside California Politics: Former LA city councilmember weighs in on mayoral race
(Inside California Politics) — With Los Angeles Mayor Karen Bass now set for a tough reelection campaign against former ally turned rival Nithya Raman, a former member of the L.A. City Council spok…
Mel Brooks turns 100: His 5 essential movies
As the legendary comedian and filmmaker marks his centennial, here's how to watch his best movies.
Mel Brooks turns 100: His 5 essential movies
As Mel Brooks turns 100 today, here are the 5 must-watch comedies from his hilarious canon of work.
Democrats Wrestle With Race, Populism and Ideology in Clashes With Lawmakers of Color
WASHINGTON (AP) — After democratic socialist Claire Valdez defeated an establishment-backed candidate in New York's congressional primary last week, her elated supporters quickly turned their attention to a new target. “You're next!” they chanted when an image of House Democratic leader Hakeem ...
I found a hidden Google Maps feature that made my Pixel's always-on display useful
A hidden Maps trick worth turning on
Yankees news: Cole can cope with commonplace stuff
Cole adjusts mid-game; Grisham set to return during homestand; Henry Lalane making waves at Low-A
Juventus hold exploratory talks for Soule’s return
Matias Soulé is among the candidates to leave Roma in the coming days and be sacrificed on the altar of capital gains. The Argentine winger isn’t pushing to leave; on the contrary, he’s stalling....
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage
Thermo Fisher Scientific Inc. (NYSE:TMO) is included among Billionaire Steven Cohen’s Top 11 Dividend Stock Picks. On June 26, Bernstein resumed coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with a Market Perform rating. It also set a $520 price target after the analyst returned from maternity leave. In a research note, the firm said “Many […]
Hawaii is turning ocean plastic and fishing nets into roads
Hawaii researchers are giving old fishing nets and recycled plastic a second life by mixing them into asphalt roads. Early tests found these roads didn't release more plastic particles than standard pavement, with tire wear overwhelming any plastic signal from the recycled material. If future studies confirm the roads are durable, the technology could help tackle both marine pollution and overflowing landfills.
Mamdani's suited pool plunge overshadowed by political clash with GOP gubernatorial candidate
Video shows Mayor Zohran Mamdani jumping into an East Harlem pool in a suit, but the event turned into a clash with Bruce Blakeman over remarks about a Dem congressional candidate.
Timberwolves Re-Sign Jaylen Clark to Three-Year Contract
Minnesota brings back its defensive specialist on a team-friendly deal during a summer full of roster turnover.
Starz Entertainment (STRZ) Stock Sees Fair Value Lift After Q1 Analyst Target Increases
Price targets for Starz Entertainment have shifted as the analyst fair value estimate moved from US$19.38 to US$28.50, putting a higher reference point in focus for investors tracking the stock. Recent Street research has turned more constructive after the Q1 report, with several firms lifting price targets and updating models to reflect how they now view execution risks and valuation support. In the sections that follow, you will see how to interpret these changing targets and what they...
Is Tencent Music Entertainment Group (TME) A Bargain Following Its Sharp Pullback?
Tencent Music Entertainment Group (TME) has drawn fresh attention after recent trading left the stock down about 9% over the past month and about 11% over the past 3 months, which has sharpened the focus on its current valuation. See our latest analysis for Tencent Music Entertainment Group. At a recent share price of $8.39, Tencent Music Entertainment Group has posted a year to date share price decline of about 53% and a 1 year total shareholder return decline of about 55%. However, the 3...
World Cup collides with religion, politics in Seattle
Pride Match turns into dramatic game as Iran and Egypt settle for 1-1 draw
Vancouver turns its Science World museum into a giant 17-story soccer ball for the World Cup
It started with a whimsical idea
Vancouver turns its Science World museum into a giant 17-story soccer ball for the World Cup
It started with a whimsical idea.
Vancouver turns its Science World museum into a giant 17-story soccer ball for the World Cup
It started with a whimsical idea. Why not transform the landmark Science World museum in downtown Vancouver, the geodesic dome-topped building not far from BC Place stadium, into a gigantic 17-story soccer ball for the World Cup?
Vancouver turns its Science World museum into a giant 17-story soccer ball for the World Cup
It started with a whimsical idea. Why not transform the landmark Science World museum in downtown Vancouver, the geodesic dome-topped building not far from BC Place stadium, into a gigantic
An au pair made my family obsessed with Argentina's World Cup run
What started as childcare turned into a friendship, a World Cup obsession, and a connection that spans two continents.
Caesars Entertainment (CZR) Expands In Maine Online Gaming, Is The Stock Already Fully Valued?
Caesars Entertainment expands digital footprint with Wabanaki Nations partnership Caesars Entertainment (CZR) is extending its partnership with three Wabanaki Nations to include online casino gaming in Maine, targeting a potential 2026 iGaming launch, subject to regulatory approvals. See our latest analysis for Caesars Entertainment. Caesars Entertainment shares have climbed over recent months, with a 90 day share price return of 16.79% and year to date gain of 28.14%. However, the 5 year...
Some paid the ultimate price to enact voting rights. Their survivors see America turning backward
It’s been six decades since the Voting Rights Act was enacted
Saturday Sports: The World Cup enters knockout stage; Serena returns to Wimbledon
NPR's Scott Simon and sportswriter Howard Bryant have a World Cup knockout stage preview and discuss Serena Williams' return to Wimbledon.
Country Star Releases New Album for the First Time in Nearly Three Years
Cody Johnson returns with his first studio album in nearly three years, featuring 16 tracks and deeply personal stories inspired by his Texas roots.
5 Hobbies You Can Turn Into Small Business Ideas
Looking to start your own business? These small business ideas let you monetize what you already love doing.
Trump tamped down fights over abortion and marriage. Conservative activists want to bring them back in 2028
Since returning to the White House, Trump has largely sidestepped causes long championed by the conservative faith movement
Former Giannis Role Players Now On Milwaukee Bucks Trading Block
The Milwaukee Bucks are turning the page to a new chapter in their franchise following the trade of Giannis Antetokounmpo to the Milwaukee Bucks. Along with opening a new era, the Bucks are also looking to move on from some of their role players during the team’s Giannis phase. Among them are Kyle Kuzma and […] The post Former Giannis Role Players Now On Milwaukee Bucks Trading Block appeared first on HEAVY.
49ers News: Gotta let the Bosa Brothers dream go…
Adam Schefter believes Joey Bosa has played his last down in the NFL“Bosa turns 31 in July. Last year was the first time he appeared in double-digit games since 2021. The 49ers would pursue an edge rusher if Nick or Mykel Williams are behind the 8-ball on their rehab. Some believe Mykel begins the season […]
From Supergirl to Muse: your complete entertainment guide to the week ahead
Milly Alcock’s Kryptonian hero bops baddies with a superdog in tow, while the Devon band return with another collection of all-caps rock
Steelers add former Cowboys part-time starter to defensive staff
The Steelers added former Cowboys safety turned coach Darian Thompson to their staff reuniting him with head coach Mike McCarthy
Crowds return to Fells Point after late-night violence hits businesses
Politics Unplugged Podcast: Headlines with Stacy Pearson and Marcus Dell’Artino
The Politics Unplugged panel breaks down a possible Arizona special session tied to ESA vouchers, union protections and ballot measures. The discussion centers on whether lawmakers could unwind late-night legislation that angered teachers, police and firefighters. They also examine Gov. Katie Hobbs’ political leverage and why both parties may have reasons to cut a deal. Later, the podcast turns to Trump tax cuts, Democratic Socialists, the White House reflecting pool controversy and the World Cup.
Nia Long explains why she turned down Prince's advances
The "Michael" actress said that she later met Prince a second time: "He was lovely, but we talked about my hair the whole time."
Nia Long explains why she turned down Prince's advances
Nia Long explained why she once shut down Prince's advances when she was young, and said that she later met the musician again when she'd gained more notoriety in Hollywood.
Return of the Rushing King, Alvin Kamara
Kamara is one of the most beloved Saints players, but what will this season be for him and the fans
4 AI Prompts to Build a Profitable One-Person Business in 2026 (The Part Every AI Influencer Skips)
Spot the one move every AI influencer skips — and turn it into your next multimillion-dollar business.
Cool Desert Nights returns to Richland with classic car show, entertainment
RICHLAND, Wash. — One of Tri-Cities’ biggest events, Cool Desert Nights, returns to Richland with a weekend of classic cars, live entertainment, food and community events.
This Week's 10 Must-Read Stories on Women in Politics: Title IX Anniversary, AI's Anti-Women Bias and Ranked-Choice Voting Victories
Weekend Reading on Women’s Representation is a weekly compilation of stories about women’s representation in politics, on boards, in sports and entertainment, in judicial offices and in the private sector in the U.S. and around the world—with a little gardening and goodwill mixed in for refreshment! Published every Friday. —This week marked the 54th anniversary of Title IX. —As the Taliban approaches the five-year mark of its return to power this August, a rare protest in western Afghanistan last week laid bare both the brutality of its rule and the resilience of those living under it. —A woman will replace Eric Swalwell in California … but for not two more months. —A study of 133 AI systems found that 44 percent demonstrated gender bias, and more than a quarter showed both gender and racial bias. ... and more.
I Went From Bedside Nurse to Business Owner By Turning a Hobby Into a Home Micro-Factory That Makes Over $100K a Year
Eric Street followed his crafting passion into business.
Trump warns ‘godless communists’ will turn cities into slums as Dems fail to fight socialist surge
Trump calls Democratic socialist primary winners "godless communists" at Faith & Freedom Coalition, warning of threats to America's founding principles.
Mel Brooks Is Turning 100! His 1 Tip for Longevity, a Healthy Life
The comedy legend and father of satire celebrates his big 100th birthday on June 28.
EA Sports College Football 27 Will Be Without Two Surprising Stars
One of the most anticipated video game releases of the year is set to arrive on July 9 when EA Sports releases College Football 27 worldwide.This marks the third consecutive annual release since the series returned after an 11-year hiatus.Players who want to be included in the game must actively opt in through a structured […] The post EA Sports College Football 27 Will Be Without Two Surprising Stars appeared first on HEAVY.
Inside the courtroom where Trump’s former adviser-turned-critic John Bolton just pleaded guilty
Trump says Iran strike in Strait of Hormuz is a ‘foolish violation’ of agreement
President Donald Trump called Iran’s strike on a vessel in the Strait of Hormuz a “foolish violation” of the agreement to end the war with Tehran, but offered little indication the episode would prompt a return to active hostilities.
Green Party returns inadmissible donation from Zack Polanski
Under UK electoral law parties can only accept money from people on the UK electoral register.
Intel’s chip business shows signs of life after years of struggle
Not long ago, Intel was seen as Silicon Valley’s fallen icon. Now it is showing signs of a turnaround amid the AI boom.
Two Yankees Pitching Prospects ‘Turning Heads’ in Minors This Year
The old saying is you can never have enough pitching, which the New York Yankees have apparently taken to heart. The Yankees have a stockpile of potential starting-pitching arms in the minor leagues, including Elmer Rodriguez, and two “head turning” prospects, Ben Hess and Chase Hampton. The Yankees lead the majors in team ERA (3.30) […] The post Two Yankees Pitching Prospects ‘Turning Heads’ in Minors This Year appeared first on HEAVY.
From The Sports Desk: The U.S. lost, but also saw return of star Christian Pulisic
The Americans may have lost their final group stage. But Pulisic, who had been nursing a calf injury, returned to action. He’s back just in time for the start of the knockout round.
Master Inventor Hoffman Turns Chemistry Into Capability | Johns Hopkins University Applied Physics Laboratory
Christopher Hoffman has been recognized as a Johns Hopkins APL Master Inventor, a distinction earned through a career spent asking a simple question: What can chemistry can do to solve a real-world problem?
Early Homo sapiens may have lived in rainforests, new clues suggest — and it could overturn our understanding of human evolution
The long-held idea that rainforests held a minor role in our species' evolution is changing — and our ability to adapt to these tropical areas may give insight about 'what it means to be uniquely human.'
Dragon's Dogma 2: Dark Arisen: What We Learned In Capcom's Showcase
Kento Kinoshita, Dragon's Dogma: Dark Arisen's original director, is returning for Dragon's Dogma 2: Dark Arisen
Morning Break: Joe Horn set for Louisiana Sports Hall of Fame induction, Bryce Lance turning heads
A collection of headlines and news about the Saints and the NFL for Friday, June 26
The Largest, Most Detailed Image of the Milky Way's 'Heart' Shows 60 Million Stars
The dark-universe telescope turned inward and caught 60 million stars.
Whole Hog Politics: It was voters, not Senate Republicans, who forced Trump’s hand on Iran
The early returns are in, and we can pretty safely say that Americans like the peace with Iran but strongly dislike the war that it ended. The truce is shaky, with hour-by-hour challenges that seem...
Scientists Turn Wet Coffee Grounds Into Coal-Like Fuel in Just 90 Seconds
A new process skips energy-intensive drying for recycling coffee waste.
Is AMC Entertainment Holdings (AMC) Undervalued Or Is Its Recent Rally Already Priced In?
AMC Entertainment Holdings (AMC) is under renewed scrutiny as investors weigh its recent share price swings and ongoing losses against reported revenue of $5,031.8 million and a market value of about $1.5 billion. See our latest analysis for AMC Entertainment Holdings. At a share price of $1.89, AMC Entertainment Holdings has seen sharp swings, with a 7 day share price return down 33.22% but a 90 day share price return up 99.33%. The 1 year total shareholder return is down 37.42%, indicating...
How Science and Music Blurred Politics One Day Back Home
What to expect when you talk and play music to people you grew up with but have not seen for decades and have different political views from you. Turns out it was fabulous.
How Science and Music Blurred Politics One Day Back Home
What to expect when you talk and play music to people you grew up with but have not seen for decades and have different political views from you. Turns out it was fabulous.
Happy birthday, 2000 Year Old Man. Mel Brooks is turning 100
The 2000 Year Old Man is turning 100. Mel Brooks on Sunday will celebrate his centennial birthday. The comedian and filmmaker has been awaiting the milestone. Earlier this year, Judd
Sam Fuld, player-turned-business exec, is a new Wharton grad. Up next: The Phillies’ future.
Last month, Fuld graduated from Penn's Wharton School and formally assumed his new role as the Phillies' president of business operations.
Online retailer John's Crazy Socks relocates to Huntington in effort to turn around business
The company's core mission is to create employment opportunities for people who face barriers to work because of disabilities.
How Perizaad Zorabian Left Bollywood And Turned Her Family's Poultry Business Into A Rs 120 Crore Enterprise
Perizaad Zorabian was at the peak of her career when she decided to quit acting and turned her focus to her family's poultry business
Introducing: Breguet Celebrates the 225th Anniversary of the Tourbillon with Four New Releases, And the Return of a Collector Favorite (Live Pics)
A revived and revised version of the Roth-designed caliber 558.1 movement (significantly improved) headlines four watches to celebrate the patent date of one of Abraham-Louis Breguet's most notable achievements.
Intel’s Chip Business Shows Signs of Life After Years of Struggle
It is the centerpiece of President Trump’s drive to make more chips in the United States, but the company still has a long way to go before it can be called a complete turnaround.
County Invites Youth, Camps To Register For ‘Mind Your Business’ July 7 - Town-Crier Newspaper
Palm Beach County’s Mind Your Business Youth Entrepreneurship Forum returns on July 7, offering a full day of hands-on learning and innovation for young people across the county. Now in its seventh year, the forum is designed to inspire the next generation of creators, problem-solvers and emerging business leaders. Open to youth ages 10 to […]
4 Takeaways From USA's Last-Second World Cup Loss To Türkiye
So much for a perfect group stage. But the USA can now turn its attention toward the knockout stages.
Elliot Cadeau appears set to return to Michigan basketball roster
For the third and presumably final time this offseason, Elliot Cadeau appears to have confirmed he will stay with Michigan basketball.
It's Xbox's turn (again), as console prices keep going up
Microsoft announced a price hike for the Xbox Series consoles today, the third in little over a year. Effective August 1, the Xbox Series S, which launched in 2020 for $300, will cost $500 in the U.S. The Xbox Series X, which launched in 2020 at $500, will go for $800. This follows a round of PlayStation 5 price increases from Sony this spring, and a slow-motion increase for Nintendo’s Switch 2, which will kick in in the U.S. in September. (Mind you, there were also eight video game industry price hikes in six months of 2025). The chart up top shows the sudden ascent of console prices over the past year, a sudden surge in an already unusual hardware generation. Prices had been flat for years, now “up” is the new “flat.” Game console prices used to go down across the length of a console generation, but not this time around. Microsoft’s explanation for the new price hike today: We hoped another price increase would not be necessary, and we have spent the last several months working with suppliers on options. Unfortunately, console storage and memory prices have increased by more than 2.5x and we expect another doubling by the fall of 2027. The entire consumer electronics industry is struggling with the current components crisis, but the effects are particularly hard on consoles. Unlike phones, computers, speakers, and other consumer devices, consoles are typically not sold at a profit, but instead for less than they cost to make. This is an issue well beyond game consoles. Apple announced price hikes on its computers and tablets today as well. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: Brutal Bungie cuts Bungie laid off “most” of its Destiny development team and some developers who worked on Marathon, the newest game from the struggling Sony-owned studio. A WARN notice issued by Sony to Washington State, where Bungie is based, tallied cuts impacting 292 workers, effective next month. That’s strictly for Bungie/Sony jobs in Washington and wouldn’t account for any elsewhere. The video I clipped below shows the redacted list of Bungie cuts filed to Washington State officials. As you’ll see, I had to scroll for a while… In a note emailed to PlayStation workers and published online, PlayStation game studios chief Hermen Hulst offered the following explanation for these latest cuts at Bungie: This is painful news, especially for talented colleagues whose roles have been eliminated. This decision was made only after extensive discussion and careful consideration, and I want to provide some context on how we arrived here. Over the past several months, together with Bungie leadership, we reviewed the studio’s long-term direction, development priorities, resource needs, and role within our broader portfolio strategy. We explored multiple alternatives before concluding that a reduction was necessary to align the studio’s resources with its current priorities and long-term goals. In 2022, Sony bought Bungie for $3.7 billion. The studio’s marquee game, the multiplayer live service shooter Destiny 2 was losing popularity at the time. Its next game Marathon, released earlier this year, has been well-reviewed but had a slow start. Bungie is renowned for making great shooter games, and Destiny fans have mourned the wind-down of Destiny 2. They’ve also expressed bewilderment over reports that Destiny 3 is not, per Bloomberg, immediately in the cards.
Lionel Richie postpones concerts after falling ill during tour opener
Lionel Richie is pausing his return to the stage after abruptly falling ill during the opening of his new tour.
Kawhi Leonard Seeks Extension – But Not With Current Team
Kawhi Leonard has one year left on his current contract with the Los Angeles Clippers. He’s eligible to sign an extension this summer, and sounds like he’s willing to do get that done. The one caveat: The Clippers aren’t necessarily the team he wants to sign with. Leonard, who turns 35 on June 29, ...
Inside Trump’s plans for retribution and other lesser-known allegations in ‘Regime Change’
A new book from two Washington reporters reveals what took place inside the White House after President Donald Trump’s return to power.
Monkey Business: Wild rhesus macaque spotted at Mount Dora hotel
A wild rhesus macaque was spotted at the historic Lakeside Inn in Mount Dora, Florida, spending about 45 minutes roaming the property and attracting attention from guests and staff. The hotel and local businesses responded with humorous, monkey-themed social media content, engaging the community. Wildlife officials cautioned the public not to approach or feed wild monkeys due to potential health risks and encouraged reporting sightings to authorities. The monkey has not returned to the hotel but has been seen elsewhere in downtown Mount Dora.
Supreme Court hands Trump major victories on his immigration agenda
In two ideologically spit rulings that could affect millions, justices say the administration can deport some migrants and turn others away at the border.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Trump keeps turning Republican wins into loyalty tests
President Donald Trump’s moves on housing, FISA, Iran and Washington projects are creating new headaches for Republicans trying to show voters they can govern.
This One Tax Move Could Save Your Company A Lot of Money
Still filing your tax returns as a "pass through" business? It may be time to change that.
Sam Panayotovich returns to Chicago, joins Fox 32 sports
He'll report on Fox 32 but also anchor Fox 32's digital sports platform.
World Cup schedule, live updates: Germany, Japan and USA return as Matchday 3 continues
Graham Platner backs legal maneuver using Maine law to rein in political spending
Democratic U.S. Senate nominee Graham Platner wants to overturn the landmark U.S. Supreme Court ruling that enabled corporations and other outside groups to spend unlimited money on elections by any means possible. He supports a constitutional amendment and ethics rules on the high court, which the Sullivan oyster farmer included in his latest policy rollout […]
World Cup schedule, live updates: USA, Group D returns Thursday as Matchday 3 continues
We're trimming a health-care stock into strength and raising our price target
It's been a remarkable turnaround for a name we started to buy a little too high and a little too fast when the Iran war broke out.
Poppi founder speaks about building a billion-dollar soda business
Allison Ellsworth, the founder of the viral soda brand Poppi, sits down with NBC News' Savannah Sellers to discuss how she turned a personal health issue into a billion-dollar cultural phenomenon.
Supreme Court hands Trump two major immigration victories
Supreme Court rules migrants turned away at the border cannot apply for asylum and blocks TPS recipients from judicial relief in two major decisions.
Supreme Court clears way for Trump administration to revive restrictive immigration policy
The justices, in a 6-3 decision, overturned a lower court order blocking the practice that limited the number of people who could apply for asylum each day.
Supreme Court allows Trump administration to end legal protections for Haitians and Syrians
The 6-3 decision overturns lower court orders and allows the Department of Homeland Security to swiftly end temporary protected status, a program that protects a total of 1.3 million people from 17 countries.
Yoga, Vinyl & Family Fun: Free Summer Entertainment Returns to Hudson Yards
NEW YORK CITY (PIX11) — Hudson Yards Turns Into NYC’s Outdoor Playground This Summer.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
KFF Poll Shows Three in Ten Adults Turn to Social Media or AI for Health Information, with Lower-Income Adults More Likely to Cite Cost and Access Barriers as a Reason
The latest KFF Tracking Poll on Health Information and Trust finds roughly three in ten adults report turning to social media (31%) or AI chatbots (29%) at least monthly for health information and advice. The top reasons people report turning to social media for health advice are wanting to hear from those with similar experiences or a desire for quick information.
Des Bishop turns a turbulent past into comedy in 'Bridge and Tunnel'
Queens-born comic Des Bishop’s new “Bridge & Tunnel” special captures his long, winding journey from Irish stardom back to New York, where he finally finds his fast-paced American voice.
Australia Faces a Trumpian Turn in Politics
Pauline Hanson’s far right One Nation is no longer an outsider on the political stage.
Monterey Motorsports Festival Announces 2026 Entertainment Lineup Headlined by Viral DJ Duo SIDEQUEST
/PRNewswire/ -- The Monterey Motorsports Festival is turning up the volume for Monterey Car Week 2026 with its biggest entertainment lineup to date, featuring...
A season of festivals, special events and America 250 celebrations
The Florida Keys is turning up the heat with summer events this season running from Key Largo to Key West. Think local traditions, world-class culinary festivals, and landmark America 250
Closed-door outburst turns into victory for Trump’s Iran negotiations
Senate Republicans flipped to reject Democrats' Iran war powers resolution, handing Trump a key win as U.S.-Iran peace deal talks continue on.
Marvin Mims Jr. shares honest thoughts about future with Broncos
Denver Broncos wide receiver/return specialist Marvin Mims Jr. seems to understand his time with the team could be nearing an end.
Hong Kong Science Fair marks five years of youth innovation
As the city’s flagship I&T education event returns, it continues to connect classroom learning with real-world invention and open doors to the international stage
Revealed – Warhammer: The Old World Made to Order miniatures
Classic baby Dragons, Ogres, and more return to the World of Legend.
Caitlin Clark Fans Outraged By WNBA 30th Anniversary Poster Snubbing
The WNBA is turning 30 years old this year. The women's basketball league, which launched 30 years ago, is celebrating three decades of ball in several different ways. One of them is a special WNBA 30th Anniversary poster, which went on-sale this week. "Bring a piece of WNBA history home. 🏀 ...
4 years after Dobbs, Texas abortion rights advocates share personal stories
In June 2022, the U.S. Supreme Court overturned Roe v. Wade, ending the constitutional right to an abortion